Evidence map›Paper›PMID 26202297›Full record

ArticleHepatology international2013

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.

Roslyn Vongsuvanh, David van der Poorten, Jacob George

Abstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature.Journal of clinical and translational hepatology · 2017
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Roslyn VongsuvanhStorr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Darcy Rd, Westmead, NSW, 2145, Australia. rvongsuv@med.usyd.edu.au.
David van der PoortenStorr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Darcy Rd, Westmead, NSW, 2145, Australia. david.vanderpoorten@sydney.edu.au.
Jacob GeorgeStorr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Darcy Rd, Westmead, NSW, 2145, Australia. jacob.george@sydney.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of hepatocellular carcinoma (HCC) in the Asia Pacific will undergo significant change over the next few decades as the prevalence of viral hepatitis declines and the burden of metabolic diseases increases. As the Asia Pacific embraces continued affluence, obesity and diabetes rates are burgeoning, becoming increasingly important to the incidence of HCC. Obesity and diabetes are established risk factors for HCC, either as substrates for non-alcoholic fatty liver disease (NAFLD) or as independent carcinogens themselves. This review summarises the epidemiological data on changing HCC trends in the Asia Pacific, particularly as it pertains to the emerging problem of NAFLD-related HCC.

Indexed as

Asia PacificDiabetesHepatocellular carcinomaNon-alcoholic fatty liver diseaseNon-alcoholic steatohepatitisObesity

Identifiers

PMID26202297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.